Brain Control of Insulin and Glucagon Secretion

Endocrinology and Metabolism Clinics of North America

Volumn 42, Issue 1, 2013, Pages 1-14

  Osundiji, Mayowa A ^a   Evans, Mark L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Autonomic control of pancreas; Glucagon; Glucose sensing; Glucose stimulated insulin secretion; Hypoglycemia; Hypothalamus; Insulin; Islets of langerhans

Indexed keywords

ADENYLATE KINASE; GLUCAGON; GLUCOSE; GLUCOSE TRANSPORTER 2; INSULIN; MELANOCORTIN;

BRAIN FUNCTION; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPOGLYCEMIA; INSULIN RELEASE; INSULIN RESPONSE; METABOLIC REGULATION; NONHUMAN; PANCREAS ISLET CELL FUNCTION; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; REVIEW; SYMPATHETIC INNERVATION;

ANIMALS; BLOOD GLUCOSE; GLUCAGON; HUMANS; HYPOTHALAMUS; INSULIN; ISLETS OF LANGERHANS; NEUROSECRETORY SYSTEMS;

EID: 84873253557     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2012.11.006     Document Type: Review

References (85)

1. Kaneto A., Kosaka K., Nakao K. Effects of stimulation of the vagus nerve on insulin secretion. Endocrinology 1967, 80(3):530-536.
2. Frohman L.A., Ezdinli E.Z., Javid R. Effect of vagotomy and vagal stimulation on insulin secretion. Diabetes 1967, 16(7):443-448.
3. Bloom S.R., Edwards A.V. Pancreatic endocrine responses to stimulation via the sympathetic innervation. J Physiol 1975, 245(2):120P-121P.
4. Pocai A., Lam T.K., Gutierrez-Juarez R., et al. Hypothalamic K(ATP) channels control hepatic glucose production. Nature 2005, 434(7036):1026-1031.
5. Unger R.H., Aquilar-Parado E., Muller W.A., et al. Studies on pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest 1970, 49:837-848.
6. Lee Y., Wang M.Y., Du X.Q., et al. Glucagon receptor knock-out prevents insulin-deficient type 1 diabetes in mice. Diabetes 2011, 60:391-397.
7. Findlay J.A., Gill J.R., Lever J.D., et al. Increased insulin output following stimulation of the vagal supply to the perfused rabbit pancreas. J Anat 1969, 104(Pt 3):580.
8. Bloom S.R., Edwards A.V. The release of pancreatic glucagon and inhibition of insulin in response to stimulation of the sympathetic innervation. J Physiol 1975, 253(1):157-173.
9. Streefland C., Maes F.W., Bohus B. Autonomic brainstem projections to the pancreas: a retrograde transneuronal viral tracing study in the rat. J Auton Nerv Syst 1998, 74:71-81.
10. Ahrén B., Taborsky G.J., Porte D. Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion. Diabetologia 1986, 29(12):827-836.
11. Ahren B., Paquette T.L., Taborsky G.J. Effect and mechanism of vagal nerve stimulation on somatostatin secretion in dogs. Am J Physiol 1986, 250:E212-E217.
12. Woods S.C., Bernstein I.L. Cephalic insulin response as a test for completeness of vagotomy to the pancreas. Physiol Behav 1980, 24:485-488.
13. Karlsson S., Ahren B. Muscarinic receptor subtypes in carbachol-stimulated insulin and glucagon secretion in the mouse. J Auton Pharmacol 1993, 13:439-446.
14. Gregersen S., Ahren B. Studies on the mechanisms by which gastrin releasing peptide stimulates insulin secretion from mouse islets. Pancreas 1996, 12:48-57.
15. Straub S.G., Sharp G.W. A wortmannin-sensitive signal transduction pathway is involved in the stimulation of insulin release by vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide. J Biol Chem 1996, 271:1660-1668.
16. Bloom S.R., Edwards A.V. Characteristics of the neuroendocrine responses to stimulation of the splanchnic nerves in bursts in the conscious calf. J Physiol 1984, 346:533-545.
17. 2+ efflux and insulin secretion from isolated rat islets. Acta Physiol Scand 1988, 132:289-296.
18. Ahren B., Lundquist I. Effects of selective and nonselective beta-adrenergic agents on insulin secretion in vivo. Eur J Pharmacol 1981, 71:93-104.
19. Ahren B. Autonomic regulation of islet hormone secretion. Implications for health and disease. Diabetologia 2000, 43:393-410.
20. Jansen A.S., Hoffman J.L., Loewy A.D. CNS sites involved in sympathetic and parasympathetic control of the pancreas: a viral tracing study. Brain Res 1997, 766:29-38.
21. Jansen A.S., Nguyen X.V., Karpitskiy V., et al. Central command neurons of the sympathetic nervous system: basis of the fight-or-flight response. Science 1995, 270:644-646.
22. Strack A.M., Sawyer W.B., Platt K.B., et al. CNS cell groups regulating the sympathetic outflow to adrenal gland as revealed by transneuronal cell body labeling with pseudorabies virus. Brain Res 1989, 491:274-296.
23. Krowicki Z.K., Hornby P.J. The nucleus raphe obscurus controls pancreatic hormone secretion in the rat. Am J Physiol 1995, 268(6 Pt 1):E1128-E1134.
24. Krowicki Z.K., Hornby P.J. Pancreatic polypeptide, microinjected into the dorsal vagal complex, potentiates glucose-stimulated insulin secretion in the rat. Regul Pept 1995, 60(2-3):185-192.
25. Guillod-Maximin E., Lorsignol A., Alquier T., et al. Acute intracarotid glucose injection towards the brain induces specific c-fos activation in hypothalamic nuclei: involvement of astrocytes in cerebral glucose-sensing in rats. J Neuroendocrinol 2004, 16(5):464-471.
26. Leloup C., Magnan C., Benani A., et al. Mitochondrial reactive oxygen species are required for hypothalamic glucose sensing. Diabetes 2006, 55(7):2084-2090.
27. Clément L., Cruciani-Guglielmacci C., Magnan C., et al. Intracerebroventricular infusion of a triglyceride emulsion leads to both altered insulin secretion and hepatic glucose production in rats. Pflugers Arch 2002, 445(3):375-380.
28. Cruciani-Guglielmacci C., Hervalet A., Douared L., et al. Beta oxidation in the brain is required for the effects of non-esterified fatty acids on glucose-induced insulin secretion in rats. Diabetologia 2004, 47(11):2032-2038.
29. Osundiji M.A., Lam D.D., Shaw J., et al. Brain glucose sensors play a significant role in the regulation of pancreatic glucose-stimulated insulin secretion. Diabetes 2012, 61(2):321-328.
30. Rohner F., Dufour A.C., Karakash C., et al. Immediate effect of lesion of the ventromedial hypothalamic area upon glucose-induced insulin secretion in anaesthetized rats. Diabetologia 1977, 13(3):239-242.
31. Paranjape S.A., Chan O., Zhu W., et al. Chronic reduction of insulin receptors in the ventromedial hypothalamus produces glucose intolerance and islet dysfunction in the absence of weight gain. Am J Physiol Endocrinol Metab 2011, 301(5):E978-E983.
32. Knauf C., Cani P.D., Perrin C., et al. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J Clin Invest 2005, 115(12):3554-3563.
33. Calegari V.C., Torsoni A.S., Vanzela E.C., et al. Inflammation of the hypothalamus leads to defective pancreatic islet function. J Biol Chem 2011, 286(15):12870-12880.
34. Fan W., Dinulescu D.M., Butler A.A., et al. The central melanocortin system can directly regulate serum insulin levels. Endocrinology 2000, 141:3072-3079.
35. Muzumdar R., Ma X., Yang X., et al. Physiologic effect of leptin on insulin secretion is mediated mainly through central mechanisms. FASEB J 2003, 17(9):1130-1132.
36. Martinelli C.E., Keogh J.M., Greenfield J.R., et al. Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion. J Clin Endocrinol Metab 2011, 96(1):E181-E188.
37. Rossi J., Balthasar N., Olson D., et al. Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis. Cell Metab 2011, 13:195-204.
38. Goldfine I.D., Abraira C., Gruenwald D., et al. Plasma insulin levels during imaginary food ingestion under hypnosis. Proc Soc Exp Biol Med 1970, 133:274-286.
39. Pavlov I. The work of the digestive glands 1902, Charles Griffin, London.
40. Wood J. The first Nobel prize for integrated systems physiology: Ivan Petrovich Pavlov, 1904. Physiology (Bethesda) 2004, 19(6):326-330.
41. Defilippi C.C., Solomon T.E., Valenzuela J.E. Pancreatic secretory response to sham feeding in humans. Digestion 1982, 23(4):217-223.
42. Sarles H., Dani R., Prezelin G., et al. Cephalic phase of pancreatic secretion in man. Gut 1968, 9(2):214-221.
43. Teff K.L., Mattes R.D., Engelman J., et al. Cephalic-phase insulin in obese and normal-weight men: relation to postprandial insulin. Metabolism 1993, 42:1600-1608.
44. Berthoud H.R., Bereiter D.A., Trimble E.R., et al. Cephalic phase, reflex insulin secretion. Neuroanatomical and physiological characterization. Diabetologia 1981, 20:393-401.
45. Strubbe J.H. Parasympathetic involvement in rapid meal-associated conditioned insulin secretion in the rat. Am J Physiol 1992, 263:R615-R618.
46. Bruce D.G., Storlien L.H., Furler S.M., et al. Cephalic phase metabolic response in normal weight adults. Metabolism 1987, 36:721-725.
47. Berthoud H.R., Trimble E.R., Siegel E.G., et al. Cephalic-phase insulin secretion in normal and pancreatic islet-transplanted rats. Am J Physiol 1980, 238:E336-E340.
48. Secchi A., Caldara R., Caumo A., et al. Cephalic-phase insulin and glucagon release in normal subjects and in patients receiving pancreas transplantation. Metabolism 1995, 44:1153-1158.
49. Grill H.J., Berridge K.C., Ganster D.J. Oral glucose is the prime elicitor of preabsorptive insulin secretion. Am J Physiol 1984, 246:R88-R95.
50. Flynn F.W., Berridge K.C., Grill H.J. Pre- and postabsorptive insulin secretion in chronic decerebrate rats. Am J Physiol 1986, 250:R539-R548.
51. Berthoud H.R., Powley T.L. Identification of vagal preganglionics that mediate cephalic phase insulin response. Am J Physiol 1990, 258(2 Pt 2):R523-R530.
52. Cox J.E., Powley T. Prior vagotomy blocks VMH obesity in pair fed rats. Am J Physiol 1981, 240:E573-E583.
53. Berthoud H.R., Jeanrenaud B. Sham feeding-induced cephalic phase insulin release in the rat. Am J Physiol 1982, 242:E280-E285.
54. Ahren B., Holst J. The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia. Diabetes 2001, 50:1030-1038.
55. Mitrakou A., Kelley D., Mokam M., et al. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 1992, 326:22-29.
56. Bruttomesso D., Pianta A., Mari A., et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes 1999, 48:99-105.
57. Teff K.L., Engelman K. Oral sensory stimulation improves glucose tolerance in humans: effects on insulin, C-peptide, and glucagon. Am J Physiol 1996, 270:R1371-R1379.
58. Lorentzen M., Madsbad S., Kehlet H., et al. Effect of sham-feeding on glucose tolerance and insulin secretion. Acta Endocrinol (Copenh) 1987, 115:84-86.
59. Calles-Escandon J., Robbins D.C. Loss of early phase of insulin release in humans impairs glucose tolerance and blunts thermic effect of glucose. Diabetes 1987, 36:1167-1172.
60. Jones B.J., Tan T., Bloom S.R. Minireview: glucagon in energy and stress homoeostasis. Endocrinology 2012, 153(3):1049-1054.
61. Taborsky G.J., Ahrén B., Havel P.J. Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired beta-cell responses in type 1 diabetes. Diabetes 1998, 47:995-1005.
62. Biggers D.W., Myers S.R., Neal D., et al. Role of brain in counterregulation of insulin-induced hypoglycemia in dogs. Diabetes 1989, 38(1):7-16.
63. Frizzell R.T., Jones E.M., Davis S.N., et al. Counterregulation during hypoglycemia is directed by widespread brain regions. Diabetes 1993, 42(9):1253-1261.
64. Andrew S.F., Dinh T.T., Ritter S. Localized glucoprivation of hindbrain sites elicits corticosterone and glucagon secretion. Am J Physiol Regul Integr Comp Physiol 2007, 292(5):R1792-R1849.
65. Saberi M., Bohland M., Donovan C.M. Describe GS and GI. The locus for hypoglycemic detection shifts with the rate of fall in glycemia: the role of portal-superior mesenteric vein glucose sensing. Diabetes 2008, 57(5):1380-1386.
66. Zhou L., Podolsky N., Sang Z., et al. The medial amygdalar nucleus: a novel glucose-sensing region that modulates the counterregulatory response to hypoglycemia. Diabetes 2010, 59(10):2646-2652.
67. Hurst P., Garfield A.S., Marrow C., et al. Recurrent hypoglycemia is associated with loss of activation in rat brain cingulate cortex. Endocrinology 2012, 153(4):1908-1914.
68. Borg W.P., During M.J., Sherwin R.S., et al. Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J Clin Invest 1994, 93(4):1677-1682.
69. Borg W.P., Sherwin R.S., During M.J., et al. Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes 1995, 44(2):180-184.
70. Borg M.A., Sherwin R.S., Borg W.P., et al. Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest 1997, 99(2):361-365.
71. Tong Q., Ye C., McCrimmon R.J., et al. Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia. Cell Metab 2007, 5(5):383-393.
72. + channels play a key role in sensing hypoglycemia and triggering counterregulatory epinephrine and glucagon responses. Diabetes 2004, 53(10):2542-2551.
73. + channels in the ventromedial hypothalamus amplifies counterregulatory hormone responses to hypoglycemia in normal and recurrently hypoglycemic rats. Diabetes 2005, 54(11):3169-3174.
74. + channels in the hypothalamus are essential for the maintenance of glucose homeostasis. Nat Neurosci 2001, 4(5):507-512.
75. Chan O., Lawson M., Zhu W., et al. ATP-sensitive K(+) channels regulate the release of GABA in the ventromedial hypothalamus during hypoglycemia. Diabetes 2007, 56:1120-1126.
76. Chan O., Zhu W., Ding Y., et al. Sherwin RS blockade of GABA(A) receptors in the ventromedial hypothalamus further stimulates glucagon and sympathoadrenal but not the hypothalamo-pituitary-adrenal response to hypoglycemia. Diabetes 2006, 55(4):1080-1087.
77. Zhu W., Czyzyk D., Paranjape S.A., et al. Glucose prevents the fall in ventromedial hypothalamic GABA that is required for full activation of glucose counterregulatory responses during hypoglycemia. Am J Physiol Endocrinol Metab 2010, 298(5):E971-E977.
78. Levin B.E., Becker T.C., Eiki J.-I., et al. Ventromedial hypothalamic glucokinase is an important mediator of the counterregulatory response to insulin-induced hypoglycemia. Diabetes 2008, 57(5):1371-1379.
79. Hurst P.H., Marsh W., Riches C.R., et al. Increased counter-regulatory responses to hypoglycaemia in mice with mutant glucokinase. Diabet Med 2011, 28(Suppl 1):30-31. A84.
80. Osundiji M.A., Godes M.L., Evans M.L., et al. BAD modulates counterregulatory responses to hypoglycemia and protective glucoprivic feeding. PLoS One 2011, 6(12):e28016.
81. Thorens B., Guillam M.T., Beermann F., et al. Transgenic reexpression of GLUT1 or GLUT2 in pancreatic beta cells rescues GLUT2-null mice from early death and restores normal glucose-stimulated insulin secretion. J Biol Chem 2000, 275(31):23751-23758.
82. Marty N., Dallaporta M., Foretz M., et al. Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocyte-dependent glucose sensors. J Clin Invest 2005, 115(12):3545-3553.
83. Beall C., Hamilton D.L., Gallagher J., et al. Ashford ML mouse hypothalamic GT1-7 cells demonstrate AMPK-dependent intrinsic glucose-sensing behaviour. Diabetologia 2012, 55(9):2432-2444.
84. McCrimmon R.J., Shaw M., Fan X., et al. Key role for AMP-activated protein kinase in the ventromedial hypothalamus in regulating counterregulatory hormone responses to acute hypoglycemia. Diabetes 2008, 57(2):444-450.
85. McCrimmon R.J., Fan X., Cheng H., et al. Activation of AMP-activated protein kinase within the ventromedial hypothalamus amplifies counterregulatory hormone responses in rats with defective counterregulation. Diabetes 2006, 55(6):1755-1760.